A BLOOD TEST THAT can predict with 90 percent accuracy if a healthy person will develop mild cognitive impairment (MCI) or Alzheimer’s disease within three years
A BLOOD TEST THAT can predict with 90 percent accuracy if a healthy person will develop mild cognitive impairment (MCI) or Alzheimer’s disease within three years has been discovered and validated by researchers at Georgetown and six other institutions.
The study team explains in the April issue of Nature Medicine (the paper was published online today) how they discovered and then validated a set of 10 lipid biomarkers in the blood that predict both conditions.
The discovery heralds the possible development of earlier treatment options for Alzheimer’s, when therapy could be more effective at slowing or even preventing onset of the disease.
“Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder,” says the study’s corresponding author, Dr. Howard J. Federoff, executive vice president of health sciences at Georgetown University Medical Center.
There is currently no cure or effective treatment for Alzheimer’s disease, which, according to the World Health Organization, is expected to double every 20 years worldwide – from 35.6 million individuals in 2010 to 115.4 million by 2050.
Federoff, also a professor of neurology, explains there have been many efforts to develop drugs to slow or reverse the progression of Alzheimer’s disease, but all of them have failed. He says one reason may be the drugs were evaluated too late in the disease process.
“The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention, and biomarkers defining this asymptomatic period are critical for successful development and application of these therapeutics,” says Federoff.
‘MAJOR STEP FORWARD’
“The lipid panel was able to distinguish with 90 percent accuracy these two distinct groups – cognitively normal participants who would progress to MCI or AD within two to three years, and those who would remain normal in the near future,” says Federoff, who also serves as executive dean of the School of Medicine.
Researchers say the panel reveals changes in the breakdown of neural cell membranes resulting in 10 identifiable lipids, or metabolites, circulating in the blood. In particular, two of the 10 metabolites have strong links to the neuropathology of Alzheimer’s.
“We consider our results a major step toward the commercialization of a preclinical disease biomarker test that could be useful for large-scale screening to identify at-risk individuals,” Federoff concludes. “We’re intending to design a clinical trial where we’ll use this panel to identify people at high risk for Alzheimer’s to test a therapeutic agent that might delay or prevent the emergence of the disease.”
The Latest on: New blood test
via Google News
The Latest on: New blood test
- Police, Health Care, Corrections Workers Have Lower Rate of Coronavirus Infection Than General New York Populationon May 13, 2020 at 11:03 am
The only exception to the New York state statistics was among members of the FDNY and emergency medical technicians.
- Microsoft and a Seattle biotech are seeking 1,000 volunteers to give blood for a virtual coronavirus study. Here's how you can enroll and make up to $250.on May 13, 2020 at 10:40 am
If you have the coronavirus or recently had it, you can sign up for a study to help researchers figure out why it makes some people so sick.
- Blood Connection offers free COVID-19 antibody testing with blood donationon May 13, 2020 at 9:35 am
The Blood Connection is still encouraging you to give blood and with that donation, they will be offering free COVID-19 antibody testing. The Blood Connection is offering ...
- ‘Today’ co-anchor Dylan Dreyer tests positive for COVID-19 antibodieson May 13, 2020 at 9:09 am
Today’s” Dylan Dreyer has revealed that she has tested positive for COVID-19 antibodies after her husband fought a “really scary” battle with coronavirus. The mother of two had just returned last week ...
- FDA fast-tracked new COVID-19 rules but Seattle blood banks may take months to implement new policy for gay, bisexual menon May 13, 2020 at 8:38 am
By Dan Facundo, UW News Lab/Special to CHS King County blood centers estimate it will take months to implement a new FDA policy for gay and bisexual male blood donors, leaving many otherwise ...
- Trials Test Survivors' Blood as COVID-19 Treatmenton May 13, 2020 at 8:23 am
Could blood plasma drawn from people who've recovered from COVID-19 help prevent new coronavirus infections or ease symptoms in those already infected?
- COVID-19 Prompts New Home Test for Kids with Organ Transplantson May 13, 2020 at 4:00 am
PRNewswire/ -- A new mail-in blood test for children with transplanted organs eliminates the need for vulnerable immunosuppressed patients to visit ...
- Wuhan to test all residents after handful of new infectionson May 12, 2020 at 11:55 pm
Authorities in the Chinese city where the coronavirus pandemic began were moving forward Wednesday with efforts to test all 11 million residents for the virus within 10 days after a handful of fresh ...
- Coronavirus antibody tests become surprising new trend at wellness spas, Botox clinics, report sayson May 12, 2020 at 7:13 pm
Across the U.S., a range of businesses are throwing in antibody tests with their normal services amid a surge in demand during the coronavirus pandemic, though health experts caution that many have ...
- US Approves New Coronavirus Teston May 12, 2020 at 2:34 pm
U.S. regulators have approved a new type of coronavirus test that administration officials have promoted as a key to opening up the country. The Food and Drug Administration on Saturday announced ...
via Bing News